My NCBI | Sign In
Search: hormone replacement therapy[majr] AND (estrogens[mh] OR estrogen replacement therapy[mh]) AND progestins[mh] AND humans[mh] AND english[la] NOT (letter[pt] OR editorial[pt]) AND "last 1 Year"[edat]
RSS Settings
  • Search: hormone replacement therapy[majr] AND (estrogens[mh] OR estrog...

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 18

    1.

    Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

    Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F.

    J Clin Oncol. 2009 Nov 1;27(31):5138-43. Epub 2009 Sep 14.PMID: 19752341 [PubMed - indexed for MEDLINE]Related articles

    2.

    Patient information. Is hormone replacement therapy for me?

    [No authors listed]

    JAAPA. 2009 Jul;22(7):58. No abstract available. PMID: 19697574 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hormone therapy and ovarian cancer.

    Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjaer S, Lidegaard O.

    JAMA. 2009 Jul 15;302(3):298-305.PMID: 19602689 [PubMed - indexed for MEDLINE]Related articles

    4.

    Postmenopausal hormone therapy and breast cancer.

    [No authors listed]

    Prescrire Int. 2009 Apr;18(100):66-7.PMID: 19585723 [PubMed - indexed for MEDLINE]Related articles

    5.

    Postmenopausal hormone treatment.

    Hulley S, Grady D.

    JAMA. 2009 Jun 17;301(23):2493-5. No abstract available. PMID: 19531791 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of hormone therapy for women aged 35 to 65 years, from contraception to hormone replacement.

    Kase NG.

    Gend Med. 2009;6 Suppl 1:37-59. Review.PMID: 19318218 [PubMed - indexed for MEDLINE]Related articles

    7.

    Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

    Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

    Am J Epidemiol. 2009 Jul 1;170(1):12-23. Epub 2009 May 25.PMID: 19468079 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hormone therapy. An update on risks and benefits.

    [No authors listed]

    Mayo Clin Womens Healthsource. 2009 Mar;Suppl:1-8. No abstract available. PMID: 19405167 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.

    Furness S, Roberts H, Marjoribanks J, Lethaby A, Hickey M, Farquhar C.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000402. Review.PMID: 19370558 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impacts on clinical decision making - changing hormone therapy management after the WHI.

    Sturmberg JP, Pond DC.

    Aust Fam Physician. 2009 Apr;38(4):249-51, 253-5.PMID: 19350076 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hormone replacement therapy diminishes hearing in peri-menopausal mice.

    Price K, Zhu X, Guimaraes PF, Vasilyeva ON, Frisina RD.

    Hear Res. 2009 Jun;252(1-2):29-36. Epub 2009 Mar 6.PMID: 19269311 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of hormones on urinary incontinence in postmenopausal women.

    Quinn SD, Domoney C.

    Climacteric. 2009 Apr;12(2):106-13. Review.PMID: 19259853 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.

    Kim JG, Ku SY, Kim H, Chun SW, Suh CS, Choi YM.

    Menopause. 2009 May-Jun;16(3):534-8.PMID: 19225428 [PubMed - indexed for MEDLINE]Related articles

    14.

    Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.

    Power ML, Anderson BL, Schulkin J.

    Menopause. 2009 May-Jun;16(3):500-8.PMID: 19169162 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.

    J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92.PMID: 19145119 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.

    Pearce CL, Chung K, Pike MC, Wu AH.

    Cancer. 2009 Feb 1;115(3):531-9. Review.PMID: 19127543 [PubMed - indexed for MEDLINE]Related articles

    17.

    Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.

    Jick SS, Hagberg KW, Kaye JA, Jick H.

    Obstet Gynecol. 2009 Jan;113(1):74-80.PMID: 19104362 [PubMed - indexed for MEDLINE]Related articles

    18.

    Breast cancer risk in postmenopausal women using estradiol-progestogen therapy.

    Lyytinen H, Pukkala E, Ylikorkala O.

    Obstet Gynecol. 2009 Jan;113(1):65-73.PMID: 19104361 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity